Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.

Inclusion Criteria: 1. Advanced carcinoma of uterine cervix histological confirmed. 2. Indication for definitive chemoradiation treatment; 3. Measurable disease by RECIST 1.1 (Response Evaluation Criteria in Solid Tumors) criteria; 4. Age between 18 years old and 70 years old; 5. Adequate bone marrow and organ function defined by laboratory values; 6. Non evidence of disease in para-aortic lymph node; Exclusion Criteria: 1. Previous treatment with Chemotherapy or radiotherapy 2. Previous surgery for primary tumor; 3. Distant metastasis; 4. Performance status according to Eastern Cooperative Oncology Group greater than 2; 5. Peripheric neuropathy greater than grade 2 by National Cancer Institute Common Toxicity Criteria for Adverse Events (NCI-CTCAE) version 3.0; 6. Significant Cardiac disease (history of and/or active disease); 7. Other treatment for cancer, including hormonotherapy; 8. Psychiatric or addictive disorders or other conditions that, in the opinion of the investigator, would preclude the patient from meeting the study requirements;